In summary, our study has revealed new biology of Treg cells in metabolic regulation and the OGT-STAT5 axis as a target to harness Treg cell function for obesity and diabetes therapeutics. The gene discussed is STAT5A; the disease is obesity due to melanocortin 4 receptor deficiency.